Skip to main content
About Us
Image Credits
Contributor Info
RSS
Log In
Join
Twitter
E-Alerts
Visit StemJournal
Main menu
About
Image Credits
Contributor Info
E-Alerts
Chapters
Cellular and nuclear reprogramming
Ectoderm specification and differentiation
Endoderm specification and differentiation
Epigenetics
Genomics and proteomics
Germ cell and somatic stem cell biology in reproduction
Manufacturing
Mesoderm specification and differentiation
Niche biology, homing, and migration
Renewal
Stem cell immunology
Therapeutic prospects
Tissue engineering
Protocols
Ectoderm differentiation
Endoderm differentiation
Genome editing
Mesoderm differentiation
Pluripotent stem cells
PSC characterization
PSC genetic stability
Reprogramming
StemLabs
Stem Cell COREdinates
Core Facility Profiles
Boston Children's Hospital Human Neuron Core
Boston University Center for Regenerative Medicine iPSC Core
Columbia Stem Cell Initiative Stem Cell Core Facility
Harvard Stem Cell Institute iPS Core Facility
Stem Cell Protocols
Stem Cell Reagents
Other Resources
News & Profiles
Latest News
Stem Cell Institute Profiles
Journal Stream
Forum
Search form
Search
You are here
Home
Biblio
Author
Title
Type
[
Year
]
Filters:
Author
is
Callander, Natalie S
[Clear All Filters]
2024
Malek E
,
Kort J
,
Metheny L
,
Fu P
,
Li G
,
Hari P
,
Efebera Y
,
Callander NS
,
Qazilbash MH
,
Giralt S
, et al.
Impact of Visceral Obesity on Clinical Outcome and Quality of Life for Patients with Multiple Myeloma: A Secondary Data Analysis of STaMINA (BMT CTN 0702) Trial.
Transplant Cell Ther. 2024.
PubMed
Google Scholar
Suvannasankha A
,
Bahlis N
,
Trudel S
,
Weisel K
,
Koenecke C
,
Oriol A
,
Voorhees PM
,
Alonso AA
,
Callander NS
,
Mateos M-V
, et al.
Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma.
Cancer. 2024.
PubMed
Google Scholar
2023
Costa LJ
,
Chhabra S
,
Medvedova E
,
Dholaria BR
,
Schmidt TM
,
Godby KN
,
Silbermann R
,
Dhakal B
,
Bal S
,
Giri S
, et al.
Minimal residual disease response-adapted therapy in newly diagnosed multiple myeloma (MASTER): final report of the multicentre, single-arm, phase 2 trial.
Lancet Haematol. 2023.
PubMed
Google Scholar
2022
Shahzad M
,
Chaudhary SGull
,
Zafar MU
,
Hassan MA
,
Hussain A
,
Ali F
,
Anwar I
,
Ahmed M
,
Ahmed N
,
Khurana S
, et al.
Impact of COVID-19 in Hematopoietic stem cell transplant recipients: A systematic review and meta-analysis.
Transpl Infect Dis. 2022.
PubMed
Google Scholar
2021
Metheny L
,
Callander NS
,
Hall AC
,
Zhang M-J
,
Bo-Subait K
,
Wang H-L
,
Agrawal V
,
A Al-Homsi S
,
Assal A
,
Bacher U
, et al.
Allogeneic Transplantation to Treat Therapy Related MDS and AML in Adults.
Transplant Cell Ther. 2021.
PubMed
Google Scholar
Shahzad M
,
Siddiqui RS
,
Anwar I
,
Chaudhary SGull
,
Ali T
,
Naseem M
,
Ahmed TF
,
Ahmed Z
,
Khurana S
,
Ahmed N
, et al.
Outcomes with CD34-selected stem cell boost for poor graft function after allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Transplant Cell Ther. 2021.
PubMed
Google Scholar
2020
D'Angelo CR
,
Sudakaran S
,
Callander NS
.
Clinical effects and applications of the gut microbiome in hematologic malignancies.
Cancer. 2020.
PubMed
Google Scholar
2014
Sharma M
,
Zhang M-J
,
Zhong X
,
Abidi MH
,
Akpek G
,
Bacher U
,
Callander NS
,
Dispenzieri A
,
Freytes CO
,
Fung HC
, et al.
Older Patients with Myeloma Derive Similar Benefit from Autologous Transplantation.
Biol Blood Marrow Transplant. 2014.
PubMed
Google Scholar